{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:26:58Z","timestamp":1791300418436,"version":"4.1.0"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2012,11,27]],"date-time":"2012-11-27T00:00:00Z","timestamp":1353974400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0044369","type":"journal-article","created":{"date-parts":[[2012,11,27]],"date-time":"2012-11-27T22:15:54Z","timestamp":1354054554000},"page":"e44369","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":34,"title":["Cyclooxygenase-2 Inhibition Attenuates Abdominal Aortic Aneurysm Progression in Hyperlipidemic Mice"],"prefix":"10.1371","volume":"7","author":[{"given":"Sarbani","family":"Ghoshal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles D.","family":"Loftin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,11,27]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1172\/JCI8931","article-title":"Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms","volume":"105","author":"R Pyo","year":"2000","journal-title":"J Clin Invest"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0741-5214(99)70216-8","article-title":"Indomethacin inhibits expansion of experimental aortic aneurysms via inhibition of the cox2 isoform of cyclooxygenase","volume":"29","author":"M Miralles","year":"1999","journal-title":"J Vasc Surg"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1161\/01.ATV.0000216119.79008.ac","article-title":"Selective cyclooxygenase-2 inhibition with celecoxib decreases angiotensin II-induced abdominal aortic aneurysm formation in mice","volume":"26","author":"VL King","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.cardiores.2006.10.015","article-title":"Genetic deficiency of cyclooxygenase-2 attenuates abdominal aortic aneurysm formation in mice","volume":"73","author":"JM Gitlin","year":"2007","journal-title":"Cardiovasc Res"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1161\/CIRCULATIONAHA.107.731398","article-title":"Microsomal prostaglandin E synthase-1 deletion suppresses oxidative stress and angiotensin II-induced abdominal aortic aneurysm formation","volume":"117","author":"M Wang","year":"2008","journal-title":"Circulation"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2165\/00003088-200038030-00003","article-title":"Clinical pharmacokinetics and pharmacodynamics of celecoxib: a selective cyclo-oxygenase-2 inhibitor","volume":"38","author":"NM Davies","year":"2000","journal-title":"Clin Pharmacokinet"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"RESEARCH0034","DOI":"10.1186\/gb-2002-3-7-research0034","article-title":"Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes","volume":"3","author":"J Vandesompele","year":"2002","journal-title":"Genome Biol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2144\/000112052","article-title":"Comparison of in vitro and in vivo reference genes for internal standardization of real-time PCR data","volume":"40","author":"R Gilsbach","year":"2006","journal-title":"Biotechniques"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1172\/JCI7818","article-title":"Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice","volume":"105","author":"A Daugherty","year":"2000","journal-title":"J Clin Invest"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1161\/01.ATV.0000085631.76095.64","article-title":"Aortic dissection precedes formation of aneurysms and atherosclerosis in angiotensin II-infused, apolipoprotein E-deficient mice","volume":"23","author":"K Saraff","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1172\/JCI118037","article-title":"Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms. An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages","volume":"96","author":"RW Thompson","year":"1995","journal-title":"J Clin Invest"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1161\/01.ATV.15.8.1145","article-title":"Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm","volume":"15","author":"T Freestone","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0301-472X(02)00890-1","article-title":"CD34 is a specific marker of mature murine mast cells","volume":"30","author":"E Drew","year":"2002","journal-title":"Exp Hematol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.1016\/S0021-9258(18)53338-X","article-title":"Expression of the protein product of the prostaglandin synthase- 2\/TIS10 gene in mitogen-stimulated swiss 3T3 cells","volume":"268","author":"DA Kujubu","year":"1993","journal-title":"J Biol Chem"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1161\/ATVBAHA.110.216481","article-title":"Influences of aortic motion and curvature on vessel expansion in murine experimental aneurysms","volume":"31","author":"CJ Goergen","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"14383","DOI":"10.1016\/S0021-9258(17)42610-X","article-title":"Actin and tropomyosin variants in smooth muscles. Dependence on tissue type","volume":"259","author":"V Fatigati","year":"1984","journal-title":"J Biol Chem"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1172\/JCI118455","article-title":"Role of CD44 in the reaction of vascular smooth muscle cells to arterial wall injury","volume":"97","author":"M Jain","year":"1996","journal-title":"J Clin Invest"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0021-9150(98)00006-9","article-title":"The differential distribution of hyaluronic acid in the layers of human atheromatic aortas is associated with vascular smooth muscle cell proliferation and migration","volume":"138","author":"E Papakonstantinou","year":"1998","journal-title":"Atherosclerosis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1152\/physrev.1995.75.3.487","article-title":"Regulation of differentiation of vascular smooth muscle cells","volume":"75","author":"GK Owens","year":"1995","journal-title":"Physiol Rev"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1006\/abbi.2001.2507","article-title":"Platelet-derived growth factor stimulates the formation of versican-hyaluronan aggregates and pericellular matrix expansion in arterial smooth muscle cells","volume":"394","author":"SP Evanko","year":"2001","journal-title":"Arch Biochem Biophys"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1161\/01.RES.0000158963.37132.8b","article-title":"Overexpression of hyaluronan in the tunica media promotes the development of atherosclerosis","volume":"96","author":"S Chai","year":"2005","journal-title":"Circ Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1161\/01.ATV.0000174129.77391.55","article-title":"Biomechanical determinants of abdominal aortic aneurysm rupture","volume":"25","author":"DA Vorp","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1161\/01.CIR.0000133279.07468.9F","article-title":"Abdominal aortic aneurysm expansion: risk factors and time intervals for surveillance","volume":"110","author":"AR Brady","year":"2004","journal-title":"Circulation"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1161\/CIRCIMAGING.108.787358","article-title":"In vivo serial assessment of aortic aneurysm formation in apolipoprotein E-deficient mice via MRI","volume":"1","author":"GH Turner","year":"2008","journal-title":"Circ Cardiovasc Imaging"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.jtcvs.2009.07.075","article-title":"Smooth muscle phenotypic modulation is an early event in aortic aneurysms","volume":"138","author":"G Ailawadi","year":"2009","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1161\/01.ATV.18.10.1625","article-title":"Matrix metalloproteinase-2 production and its binding to the matrix are increased in abdominal aortic aneurysms","volume":"18","author":"V Davis","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1161\/01.CIR.104.3.304","article-title":"Ubiquitous elevation of matrix metalloproteinase-2 expression in the vasculature of patients with abdominal aneurysms","volume":"104","author":"S Goodall","year":"2001","journal-title":"Circulation"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1172\/JCI0215334","article-title":"Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms","volume":"110","author":"GM Longo","year":"2002","journal-title":"J Clin Invest"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0008-6363(97)00030-8","article-title":"Expression of phenotype- and proliferation-related genes in rat aortic smooth muscle cells in primary culture","volume":"34","author":"A Hultgardh-Nilsson","year":"1997","journal-title":"Cardiovasc Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"C191","DOI":"10.1152\/ajpcell.00417.2008","article-title":"TGF-beta suppresses the upregulation of MMP-2 by vascular smooth muscle cells in response to PDGF-BB","volume":"298","author":"GM Risinger Jr","year":"2010","journal-title":"Am J Physiol Cell Physiol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.bbrc.2010.10.019","article-title":"Angiotensin II-induced smooth muscle cell migration is mediated by LDL receptor-related protein 1 via regulation of matrix metalloproteinase 2 expression","volume":"402","author":"HO Jung","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1053\/ejvs.2002.1675","article-title":"Enhanced invasive properties exhibited by smooth muscle cells are associated with elevated production of MMP-2 in patients with aortic aneurysms","volume":"24","author":"S Goodall","year":"2002","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/ng1721","article-title":"Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm\/aortic dissection and patent ductus arteriosus","volume":"38","author":"L Zhu","year":"2006","journal-title":"Nat Genet"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1038\/ng.2007.6","article-title":"Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic aortic aneurysms and dissections","volume":"39","author":"DC Guo","year":"2007","journal-title":"Nat Genet"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1093\/hmg\/ddm201","article-title":"MYH11 mutations result in a distinct vascular pathology driven by insulin-like growth factor 1 and angiotensin II","volume":"16","author":"H Pannu","year":"2007","journal-title":"Hum Mol Genet"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/cvr\/cvq230","article-title":"TGFBR2 mutations alter smooth muscle cell phenotype and predispose to thoracic aortic aneurysms and dissections","volume":"88","author":"S Inamoto","year":"2010","journal-title":"Cardiovasc Res"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0140-6736(05)70270-1","article-title":"Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study","volume":"365","author":"DJ Graham","year":"2005","journal-title":"Lancet"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1136\/bmj.330.7504.1366","article-title":"Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis","volume":"330","author":"J Hippisley-Cox","year":"2005","journal-title":"BMJ"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"e1001098","DOI":"10.1371\/journal.pmed.1001098","article-title":"Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies","volume":"8","author":"P McGettigan","year":"2011","journal-title":"PLoS Med"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1161\/CIRCULATIONAHA.108.764530","article-title":"Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: the cross trial safety analysis","volume":"117","author":"SD Solomon","year":"2008","journal-title":"Circulation"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ahj.2008.12.014","article-title":"Rationale, design, and governance of prospective randomized evaluation of celecoxib integrated safety versus ibuprofen or naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis","volume":"157","author":"MC Becker","year":"2009","journal-title":"Am Heart J"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0044369","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T12:36:27Z","timestamp":1643718987000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0044369"}},"subtitle":[],"editor":[{"given":"Harald H. H. W.","family":"Schmidt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,11,27]]},"references-count":41,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2012,11,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0044369","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,27]]}}}